The EGFR, PDGFRα, MGMT, and isocitrate dehydrogenase 1 (IDH1) pathways promote GBM therapeutic resistance, which is associated with or modulated by the assembly and disassembly of PCs [132]. The gene discussed is MGMT; the disease is glioblastoma.